Colorectal Cancer

Oncology Solutions

The global burden of colorectal cancer (CRC) is expected to increase by 60 percent to more than 2.2 million new cases and 1.1 million deaths by 2030.1 Colorectal cancer is the third most common cancer diagnosed in both men and women in the United States. While the participation rates in screening are increasing, one quarter of the adults aged 50 to 75 years have never been screened.2 The five-year survival rate for colon cancer found at the local stage is 90 percent, highlighting the benefits of early detection.3

The Patient Journey

  • Early Detection

    Advantage CTC Pro3D EC

    Efficient reading workflow solution for colonic lesion detection.
  • Diagnosis

    Revolution CT

    Get uncompromised image quality and clinical capabilities through the convergence of coverage, spatial resolution, temporal resolution and spectral imaging.
  • Staging

    Computed Tomography

    저선량에서 더 높은 생산성과 효율성을 제공하는 고품질의 환자 치료의 중요성이 점점 높아지고 있습니다.  따라서 GE는 이러한 의료진의 요구에 부응할 수 있는 CT 시스템 개발에 최선을 다하고 있습니다. 
    의료진은 GE Healthcare 의 CT 제품군 중에서 정확한 영상화 요구에...
  • Treatment Planning

    Discovery RT

    Discovery RT is a comprehensive radiation therapy solution that allows you to see all that your CT can see.
  • Follow up

    SIGNA™ PET/MR with QuantWorks – 60cm

    Introducing SIGNA™ PET/MR with QuantWorks. Built with pioneering TOF and integrated with a 3.0T MR, its impressive quantitative accuracy and high count rate combined with ...

The latest in Oncology

1. Global patterns and trends in colorectal cancer incidence and mortality. Melina Arnold1, Mónica S Sierra1, Mathieu Laversanne1, Isabelle oerjomataram1, Ahmedin Jemal2, Freddie Bray1. Arnold M, et al. Gut 2017;66:683–691. doi:10.1136/gutjnl-2015-310912 683
2. cancer